KRAS and leukemia: On the contrary, preleukemic cells at early stages of leukemia development lacked NOTCH1 mutations and were unable to generate leukemia in secondary recipients [225], indicating that the acquisition of NOTCH1 mutations increases KRAS-induced T-ALL aggressiveness.